Menu

Blog

Page 9234

Jan 3, 2019

DNA-testing company 23andMe has signed a $300 million deal with a drug giant. Here’s how to delete your data if that freaks you out

Posted by in categories: biotech/medical, genetics

Popular spit-in-a-tube genetics-testing companies like Ancestry and 23andMe can — and frequently do — sell your data to drugmakers. But on Wednesday, one of those partnerships became much more explicit, when the pharmaceutical giant GlaxoSmithKline announced it was acquiring a $300 million stake in 23andMe.

As part of a four-year deal between the two companies, GlaxoSmithKline will comb 23andMe’s genetic data to look for new drugs to develop, also referred to as drug targets. It will also use the genetic data to inform how patients are selected for clinical trials.

If that news has you thinking about how your own genetic material is being used for research, know that though the DNA you submit to these services is ostensibly anonymized, leaks can happen, and privacy advocates say that such incidents could allow your data to find its way elsewhere, perhaps without your knowledge.

Continue reading “DNA-testing company 23andMe has signed a $300 million deal with a drug giant. Here’s how to delete your data if that freaks you out” »

Jan 3, 2019

Brain Autopilot: The Brain’s Default Mode

Posted by in category: robotics/AI

Your brain has an autopilot mode.

Read more

Jan 3, 2019

An Interview with Dr. Leonid Peshkin

Posted by in categories: biotech/medical, life extension, robotics/AI

In this interview, Dr. Leonid Peshkin offers insights on aging, the pitfalls of excessive optimism, and the role of machine learning in studying age-related disease.


Determined but not complacent, grounded but hopeful, Dr. Leonid Peshkin is one of the scientists working on understanding aging so that it may one day be treated like we treat any other ailment.

As he revealed in an interview with the Boston Globe in mid-2018, the idea of having to lose oneself and one’s loved ones to aging never made any sense to him, and ever since he was a child, he has been preoccupied with aging and the fear that it might take away his father, who was almost 60 when Leon was 10 and, sadly, passed away in July 2018 at the age of 96.

Continue reading “An Interview with Dr. Leonid Peshkin” »

Jan 3, 2019

Magic Whale Formula

Posted by in categories: business, cryptocurrencies, finance

The 3 key ingredients for attracting investors to your crowdfunding (ICO/STO) campaign

Below is a redacted and slightly edited and updated version of a memo provided to a client regarding how to attract investors to their business, in mid 2017. For background, they’re a 5 year old private investment firm, whose stock is traded OTC and who invest in startups focused on blockchain tech. To further this model they were exploring additional ways to raise capital, specifically to acquire more startups. Below is a high level framework of what investor “whales” are looking for. This is not investment advice. These are redacted insights into what you should be considering if you’re looking to also engage potential investors in your business enterprise.

If you don’t have time to read it all, I’ll summarize: It still takes money to make money.

Note — all crowdfunding campaigns (regardless of if you call them ICOs / STOs) require a legitimate business model, tangible solutions to real problems, market size worth investing in and the potential for 100x returns. Otherwise, whales aren’t interested in 10x returns.

Continue reading “Magic Whale Formula” »

Jan 3, 2019

How Space and Time Could Be a Quantum Error-Correcting Code

Posted by in categories: computing, quantum physics

The same codes needed to thwart errors in quantum computers may also give the fabric of space-time its intrinsic robustness.

Read more

Jan 3, 2019

This Humanoid Robot Can (Slowly) Install Drywall All by Itself

Posted by in category: robotics/AI

Coming soon to a construction site near you…

Read more

Jan 3, 2019

The US and China are in a quantum arms race that will transform warfare

Posted by in categories: military, quantum physics

Radar that can spot stealth aircraft and other quantum innovations could give their militaries a strategic edge.

Read more

Jan 3, 2019

Neutrogena is Printing Custom Face Masks That Fit You Perfectly

Posted by in category: futurism

No one cared who I was until I put on the mask (and my skin cleared up.)

Read more

Jan 3, 2019

This Facial Recognition App Remembers Names so You Don’t Have To

Posted by in categories: mobile phones, robotics/AI

SocialRecall says it deletes obsolete user data on the event version of the app, and that data for the other version is only stored on a user’s phone.

But privacy experts are still concerned that the app represents a mainstream rollout of technology that could have profound implications for the future of public spaces — and that it’s difficult to adequately inform users about the long-term risks of a technology that’s still so new.

“The cost to everyone whom you are surveilling with this app is very, very high,” New York University law professor Jason Schultz told Scientific American, “and I don’t think it respects the consent politics involved with capturing people’s images.”

Read more

Jan 3, 2019

Another blood pressure medication has been recalled over cancer-causing impurity

Posted by in category: biotech/medical

We had no shortage of blood pressure medication recalls in 2018, with multiple companies issuing warnings over drug impurities that could cause cancer. It looks like that trend will continue in 2019 as yet another company has issued a recall of blood pressure tablets after detecting an impurity that may be cancer-causing.

This time around it’s Aurobindo Pharma USA Inc, which is recalling prescriptions of the drug Valsartan, you may remember, has been the subject of recalls due to such impurities in the past. The drug is sold by several manufacturers, and in July of 2018 almost a half-dozen companies were forced to recall their products due to the discovery of human carcinogens in the tablets.

Read more